Skip to Main Content

Paper Details

Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets.
Nat Cancer
53
2020
CD205, CDX-301, DC, DCs, DEC-205, Flt3, Flt3 ligand, Flt3L, NY-ESO-1, T cells, TLR3, anti-, anti-DEC-205, antigen-presenting cells, cDC2, cDCs, conventional DCs, cross-presenting cDC1, dendritic cell, dendritic cell subsets, fms-like tyrosine kinase 3, gene signatures, innate immune cells, melanoma, natural killer cells, patients, peripheral monocytes, plasmacytoid DCs, tyrosine
Author NameAffiliation
Anna C PavlickNYU Perlmutter Cancer Center
Davide Bedognetti
Patrick J Danaher
Mary L DisisUniversity of Washington
  • 1 - 4

Datasets

Release 1.2